Immuron Limited (IMRN:NASDAQ) closed at $0.982 on October 16, 2026, down 4.65% on the day. The stock trades 58.2% below its 52-week high of $2.35 and 45.1% above its 52-week low of $0.677. Over the past year, it lost 55.6%. Immuron Limited is part of the Health Care sector (Major Pharmaceuticals).
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -5.57% | -16.77% | -13.09% | +2.52% | -55.56% |
In 252 trading sessions since October 16, 2025, IMRN closed higher on 100 days (40%). Its best day was September 4, 2026 (+62.16%) and its worst was December 10, 2025 (-25.83%). The stock moved 10% or more in a single session 20 times. It opened at least 5% above the previous day's high 2 times.
Immuron Ltd is a biopharmaceutical company which develops polyclonal antibodies for the treatment and prevention of diseases. It products include Travelan, IMM-124E for NASH and IMM-529 for Clostridium difficile infection.
Find more stocks like IMRN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.